| Similar Articles |
|---|
 |
Science News
June 30, 2007 |
Science Safari: Bad Science A popular blog that looks at science and medicine through a skeptical lens.   |
The Motley Fool
August 6, 2011
Arundhati Parmar |
Medtronic Jobs: Firm Will Double Chinese Workforce in 4 Years The company puts its focus on emerging markets. |
The Motley Fool
August 4, 2011
Arundhati Parmar |
Medtronic Infuse Device Will Be Reviewed by Yale Researchers Medtronic works with Yale on a first-of-its-kind independent review. |
BusinessWeek
March 7, 2005 |
Dr. Oesterle's Stimulating Work Medtronic's chief medical officer, Dr. Stephen N. Oesterle, discusses the progress and potential of using "implanted pulse generators" to treat chronic ailments. |
Fast Company
February 1, 2007
Kathryn Tuggle |
Fast Talk: Marathon Man Medtronic's Stephen Oesterle gets patients to run 26 miles with him -- to promote the medical-device maker, of course -- and also to show the world that chronically sick people can live full lives. |
Popular Mechanics
March 2007
Alex Hutchinson |
Forget Fisheye: A Photo Lens to Steer Robots A lens developed by South Korean researchers offers a wide-angle view without fisheye distortion, perfect for ceiling-mounted security cameras. Unlike images produced by fisheye lenses, straight lines appear straight. |
The Motley Fool
April 27, 2011
Arundhati Parmar |
Medtronic and Eli Lilly Join Hands to Combat Parkinson's Disease The partnership aims to research and develop a new approach to treating the debilitating disease. |
BusinessWeek
July 5, 2004
Michael Arndt |
High Tech -- And Handcrafted Despite a recent recall, medical-products maker Medtronic sets the quality standard for heart care. |
The Motley Fool
October 22, 2011
Harsh Chauhan |
This Stock May Be a Surprisingly Good Buy Medtronic's moves could reap dividends in the future. |
The Motley Fool
November 18, 2011
Brian Orelli |
Medtronic: Cutting Fat and Growing Margins The company announces that it has sold Physio-Control to private-equity fund Bain Capital. |
The Motley Fool
May 26, 2005
Stephen D. Simpson |
A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges? |
